Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Antimicrobial Peptides, Nanotechnology, And Natural Metabolites As Novel Approaches For Cancer Treatment
M. Leite, N. B. da Cunha, F. Costa
Published 2018 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
ABSTRACT Despite the advances in tumor identification and treatment, cancer remains the primary driver of death around the world. Also, regular treatments for the disease are incapable of targeting particular cancer types at different stages since they are not specifically focused on harmful cells since they influence both solid and tumor cells, causing side effects and undesirable symptoms. Therefore, novel strategies should be developed to treat this disease. Several efforts have been made in this direction to find more effective alternatives to cancer treatment, such as the use of antimicrobial peptides (AMPs) with antitumoral activity, nanocarriers and natural compounds from a variety of sources. AMPs are more specific to their targets because of electrostatic interaction between AMPs and the cancer cells' plasma membrane. Nanocarriers may be used for the delivery of non‐soluble drugs, which are poorly stable or require a controlled release. In addition, natural compounds have been a rich source of anti‐cancer agents for decades. In this review, these three approaches will be discussed, showing recent advances and advantages of using these strategies to treat cancer as well as the combination of these approaches increasing anticancer activity.
This paper references
The role of natural polyphenols in cell signaling and cytoprotection against cancer development.
H. Lewandowska (2016)
Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.
M. L. Patil (2009)
Treg cells as potential cellular targets for functionalized nanoparticles in cancer therapy.
H. Jonuleit (2016)
: Clinical relevance and therapeutic implications
M. E. Silva-Stenico (2013)
Aeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine Drug
Javier A. García-Vilas (2015)
New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy.
K. Gardikis (2010)
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
T. Hamaguchi (2005)
Phosphoinositide-mediated oligomerization of a defensin induces cell lysis
I. K. Poon (2014)
Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III study.
V. Lorusso (2014)
Carbon nanotubes in hyperthermia therapy.
R. Singh (2013)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.
H. Maeda (2013)
Space Flight Effects on Antioxidant Molecules in Dry Tardigrades: The TARDIKISS Experiment
A. Rizzo (2015)
iRGD peptide as effective transporter of CuInZnxS2+x quantum dots into human cancer cells.
Łucja Przysiecka (2016)
Stimulus-responsive targeted nanomicelles for effective cancer therapy.
M. Muthu (2009)
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
N. Huynh (2010)
A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle
H. Burris (2016)
Nanoparticles for thermal cancer therapy.
E. Day (2009)
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment
Jamie S. Mader (2006)
Facile Fabrication of Bi2WO6/Ag2S Heterostructure with Enhanced Visible-Light-Driven Photocatalytic Performances
R. Tang (2016)
From antimicrobial to anticancer peptides
D. Gaspar (2013)
Nano-encapsulation of olive leaf phenolic compounds through WPC-pectin complexes and evaluating their release rate.
Adeleh Mohammadi (2016)
Cancer nanotechnology: application of nanotechnology in cancer therapy.
R. Misra (2010)
Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
E. Glukhov (2008)
Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer.
Anita K. Bakrania (2016)
Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics.
D. Gaspar (2015)
Metabolomics study on the antitumor effect of marine natural compound flexibilide in HCT-116 colon cancer cell line.
D. Gao (2016)
Targeted nanosystems: Advances in targeted dendrimers for cancer therapy.
H. Yang (2016)
Membrane disrupting lytic peptides for cancer treatments.
C. Leuschner (2004)
A Predictive Model for Selective Targeting of the Warburg Effect through GAPDH Inhibition with a Natural Product.
Maria V. Liberti (2017)
Phase I clinical trial of pegylated liposomal mitoxantrone plm60-s: pharmacokinetics, toxicity and preliminary efficacy
J. Yang (2014)
Combination of dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating ovarian cancer.
Shashwati Kala (2014)
Future directions for peptide therapeutics development.
Allan A. Kaspar (2013)
Toluhydroquinone, the secondary metabolite of marine algae symbiotic microorganism, inhibits angiogenesis in HUVECs.
Nan-Hee Kim (2015)
The rise and rise of stealth nanocarriers for cancer therapy: Passive versus active
N. T. Huynh (2010)
Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa
Che Wang (2016)
Mechanism of Anticancer Effects of Antimicrobial Peptides
X. Liu (2015)
Antimicrobial Peptides and Their Analogs: Searching for New Potential Therapeutics
K. Midura-nowaczek (2014)
From Diagnosis to Treatment: Clinical Applications of Nanotechnology in Thoracic Surgery.
Christopher S Digesu (2016)
Electrochemical noise and impedance of Au electrode/electrolyte interfaces enabling extracellular detection of glioma cell populations
P. R. F. Rocha (2016)
Graphene quantum dots for cancer targeted drug delivery.
D. Iannazzo (2017)
PLGA Nanoparticles and Their Versatile Role in Anticancer Drug Delivery.
Iliyas Khan (2016)
PE and PS Lipids Synergistically Enhance Membrane Poration by a Peptide with Anticancer Properties
N. B. Leite (2015)
Anticancer peptides from bacteria. Bangladesh
T. M. Karpiński (2013)
Polymeric nanoparticle encapsulation of a naturally occurring plant scopoletin and its effects on human melanoma cell A375.
A. Khuda-Bukhsh (2010)
Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine.
A. Tan (2011)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
M. Vétizou (2015)
Helical microtubules of graphitic carbon
S. Iijima (1991)
From antimicrobial to anticancer peptides. A review
D. Gaspar (2013)
ff ects of surface modi fi cation of quantum dots on viability and migration of triple - negative breast cancer cells
BMAP-28, an Antibiotic Peptide of Innate Immunity, Induces Cell Death through Opening of the Mitochondrial Permeability Transition Pore
A. Risso (2002)
Role of Helicity on the Anticancer Mechanism of Action of Cationic-Helical Peptides
Y. Huang (2012)
cRGD-functionalized polymer micelles for targeted doxorubicin delivery.
N. Nasongkla (2004)
Detecting conservation benefits of marine reserves on remote reefs of the northern GBR
Carolina Castro-Sanguino (2017)
Structure, assembly and dynamics of macromolecular complexes by single particle cryo-electron microscopy
A. Durand (2013)
Phospholipids as cancer biomarkers: Mass spectrometry-based analysis.
R. Bandu (2018)
Phase I study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
T. Chang (2014)
Nanocarriers as an emerging platform for cancer therapy
S. Wise (2007)
The impact of epigenomics on future drug design and new therapies.
Christopher A. Hamm (2011)
Folic acid targeted Mn:ZnS quantum dots for theranostic applications of cancer cell imaging and therapy
I. Bwatanglang (2016)
Paclitaxel-loaded polymeric micelle (230 mg/m(2)) and cisplatin (60 mg/m(2)) vs. paclitaxel (175 mg/m(2)) and cisplatin (60 mg/m(2)) in advanced non-small-cell lung cancer: a multicenter randomized phase IIB trial.
S. Lee (2013)
Mode of action of cationic antimicrobial peptides defines the tethering position and the efficacy of biocidal surfaces.
M. Bagheri (2012)
Microbiome-wide association studies link dynamic microbial consortia to disease
J. Gilbert (2016)
Anti‐microbial peptides: from invertebrates to vertebrates
Philippe Bulet (2004)
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.
A. Salvati (2013)
Discovery of microbial natural products by activation of silent biosynthetic gene clusters
P. Rutledge (2015)
Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin*
Tianhua Zhang (2014)
Polymeric drugs for e ffi cient tumor - targeted drug delivery based on EPR
H. Maeda (2013)
Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites
X. Chen (2016)
Polymeric Micelles for Multi-Drug Delivery in Cancer
H. Cho (2014)
Multi-functional vesicles for cancer therapy: The ultimate magic bullet.
L. Tavano (2016)
The Hallmarks of Cancer
D. Hanahan (2000)
The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro.
S. McKeown (2006)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida (2013)
Isolation and characterization of bioactive metabolites from Xylaria psidii, an endophytic fungus of the medicinal plant Aegle marmelos and their role in mitochondrial dependent apoptosis against pancreatic cancer cells.
D. Arora (2016)
The potential legacy of cancer nanotechnology: cellular selection.
H. Patra (2014)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Ayelet Sivan (2015)
Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside.
Simone Maria-Neto (2015)
Daptomycin Resistance in Enterococci Is Associated with Distinct Alterations of Cell Membrane Phospholipid Content
N. Mishra (2012)
Dendrimer-based nanoparticles for cancer therapy.
J. Baker (2009)
Crossover from a heavy fermion to intermediate valence state in noncentrosymmetric Yb2Ni12(P,As)7
W. Jiang (2015)
A Novel Class of Emerging Anticancer Compounds: Oxyprenylated Secondary Metabolites from Plants and Fungi.
S. Genovese (2015)
Facile Control over the Supramolecular Ordering of Self-assembled Peptide Scaffolds by Simultaneous Assembly with a Polysacharride
R. Li (2017)
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
H. Maeda (2009)
Carbon nanotubes for cancer therapy and neurodegenerative diseases.
Elena Daniela Meliţă (2015)
J. Li (2017)
Nanotechnology for cancer treatment
W. Gmeiner (2015)
Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer
S. Strieth (2014)
Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells
T. Arpornsuwan (2014)
Peptides with Dual Antimicrobial and Anticancer Activities
Mário R Felício (2017)
Role of tumor vascular architecture in drug delivery.
A. Narang (2011)
Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma.
D. Straus (2014)
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
F. Danhier (2010)
Nanodiamonds coupled with plant bioactive metabolites: a nanotech approach for cancer therapy.
A. Gismondi (2015)
Nanotechnology and its Relationship to Interventional Radiology. Part II: Drug Delivery, Thermotherapy, and Vascular Intervention
S. Power (2010)
High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
G. Adams (2001)
Sea Cucumbers Metabolites as Potent Anti-Cancer Agents
N. Janakiram (2015)
Cell membrane modulation as adjuvant in cancer therapy.
S. Zalba (2017)
Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells.
Yusuf A Haggag (2017)
Quantitative control of active targeting of nanocarriers to tumor cells through optimization of folate ligand density.
Zhaomin Tang (2014)
In Vitro Activity of Aurein 1.2 Alone and in Combination with Antibiotics against Gram-Positive Nosocomial Cocci
A. Giacometti (2007)
Lichen Secondary Metabolites in Flavocetraria cucullata Exhibit Anti-Cancer Effects on Human Cancer Cells through the Induction of Apoptosis and Suppression of Tumorigenic Potentials
T. Nguyen (2014)
Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer
R. Gottardi (2013)
Structural basis for molecular recognition of folic acid by folate receptors
C. Chen (2013)
Hostdefence peptides from the glandular secretions of amphibians: Structure and activity
T. L. Pukala (2006)
Polymeric nanoparticles for cancer therapy
S. Parveen (2008)
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies
J. Deeken (2012)
Model Membrane and Cell Studies of Antimicrobial Activity of Melittin Analogues.
Elaheh Jamasbi (2016)
Nucleic acid-based approaches to investigate microbial-related cheese quality defects
D. O'sullivan (2013)
Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis
H. Gali-Muhtasib (2015)
pH-Responsive fluorescent graphene quantum dots for fluorescence-guided cancer surgery and diagnosis.
Zetan Fan (2017)
Liposome-based drug co-delivery systems in cancer cells.
Sepideh Zununi Vahed (2017)
Anticancer peptide NK-2 targets cell surface sulphated glycans rather than sialic acids
S. Gross (2012)
Quality specifications for peptide drugs: a regulatory‐pharmaceutical approach
Valentijn Vergote (2009)
Myotax: a phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
E. Curtit (2011)
Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicines
K. Greish (2007)
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors
F. Costa (2004)
Extravasation of polymeric nanomedicines across tumor vasculature.
M. Danquah (2011)
Dendrimers and dendritic polymers in drug delivery.
E. Gillies (2005)
Indole diketopiperazines from endophytic Chaetomium sp 88194 induce breast cancer cell apoptotic death
Fu-qian Wang (2015)
Epigenetic activities of flavonoids in the prevention and treatment of cancer
C. Busch (2015)
Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses
C. Piyathilake (2016)
Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the “Supply Problem”
N. G. M. Gomes (2016)
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing
I. Bernardis (2016)
Dendrimers in cancer therapeutics and diagnosis.
R. Guo (2012)
Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.
S. Dennison (2006)
Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy
J. Li (2017)
Anticancer peptides and proteins: a panoramic view.
M. S. Libério (2013)
The cyanobacterial metabolite nocuolin a is a natural oxadiazine that triggers apoptosis in human cancer cells
Kateřina Voráčová (2017)
Paclitaxel-loaded polymeric micelles radiosensitize tumors via an oxygen effect
F. Danhier (2012)
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
R. Hancock (2006)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
S. Viaud (2013)
Dendronized nanoconjugates of lysine and folate for treatment of cancer.
K. Jain (2014)
16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment
R. Guerrero-Preston (2016)
Anticancer mechanisms of temporin-1CEa, an amphipathic α-helical antimicrobial peptide, in Bcap-37 human breast cancer cells.
Che Wang (2013)
INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
Y. Wu (2011)
Correlation of Cell Membrane Lipid Profiles with Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus
N. Mishra (2012)
Antimicrobial peptides: Clinical relevance and therapeutic implications
Fabiano Pinheiro da Silva (2012)
Plant Antimicrobial Peptides as Potential Anticancer Agents
J. Guzmán-Rodríguez (2015)
Micronutrient Intakes among Women of Reproductive Age in Vietnam
P. Nguyen (2014)
The expanding scope of antimicrobial peptide structures and their modes of action.
L. T. Nguyen (2011)
Heterogeneity of mprF Sequences in Methicillin-Resistant Staphylococcus aureus Clinical Isolates: Role in Cross-Resistance between Daptomycin and Host Defense Antimicrobial Peptides
A. Bayer (2014)
Induction of apoptosis against cancer cell lines by four ascomycetes (endophytes) from Malaysian rainforest.
N. A. M. N. Hazalin (2012)
Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells
Guimiao Lin (2017)
Therapeutic applications of carbon nanotubes: opportunities and challenges.
G. Rogers-Nieman (2014)
Microfluidic systems and microreactors for the synthesis of new types of nanomaterials and nanomaterials of particularly high quality
J. Köhler (2014)
Antiproliferative Scalarane-Based Metabolites from the Red Sea Sponge Hyrtios erectus
Sameh S Elhady (2016)
Anticancer activity of CopA3 dimer peptide in human gastric cancer cells
J. Lee (2015)
Liposome-encapsulated anticancer drugs: still waiting for the magic bullet?
R. Fanciullino (2009)
The Effect of Selective D- or Nα-Methyl Arginine Substitution on the Activity of the Proline-Rich Antimicrobial Peptide, Chex1-Arg20
W. Li (2017)
Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells.
Y. Han (2013)
Lichen Secondary Metabolite, Physciosporin, Inhibits Lung Cancer Cell Motility
Yi Yang (2015)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.
J. Fang (2011)
A. Bahar (2013)
Antimicrobial peptides in animals and their role in host defences.
K. Brogden (2003)
Gliotoxin Inhibits Proliferation and Induces Apoptosis in Colorectal Cancer Cells
J. Chen (2015)
AApeptides as a New Class of Antimicrobial Agents
Youhong Niu (2013)
Host-defence peptides from the glandular secretions of amphibians: structure and activity.
T. Pukala (2006)
Lamellarin O, a Pyrrole Alkaloid from an Australian Marine Sponge, Ianthella sp., Reverses BCRP Mediated Drug Resistance in Cancer Cells
Xiao-cong Huang (2014)
Erratum to: Nuclear envelope structural defect underlies the main cause of aneuploidy in ovarian carcinogenesis
Callinice D. Capo-chichi (2016)
Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways
Zhi Zheng (2017)
Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies
X. Jin (2016)
Natural products from cyanobacteria with antimicrobial and antitumor activity.
M. E. Silva-Stenico (2013)
Release of Biologically Functional Interferon-Alpha from a Nanochannel Delivery System
Gregory B. Lesinski (2005)
Nanocarriers: promising vehicle for bioactive drugs.
M. Rawat (2006)
Passive targeting of nanoparticles to cancer: A comprehensive review of the literature.
R. Bazak (2014)
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
Paulina Kosikowska (2016)
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Y. Matsumura (1986)
Role of lipids in the interaction of antimicrobial peptides with membranes.
Vitor Teixeira (2012)
Cell biology as the basis of a better understanding of cancer
D. Wheatley (2005)
Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides
K. C. Mulder (2013)
Natural products from aquatic eukaryotic microorganisms for cancer therapy: Perspectives on anti-tumour properties of ciliate bioactive molecules.
E. Catalani (2016)
Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts
A. Hilchie (2011)
An update on applications of nanostructured drug delivery systems in cancer therapy: a review
Seyed Mohsen Aberoumandi (2017)
Short-Term Local Adaptation of Historical Common Bean (Phaseolus vulgaris L.) Varieties and Implications for In Situ Management of Bean Diversity
Stephanie M. Klaedtke (2017)
Hallmarks of Cancer: The Next Generation
M. Roizen (2012)
Carbon Nanomaterials for Drug Delivery and Cancer Therapy.
Mrinmay Chakrabarti (2015)
The Crux of the Medicine Prices' Controversy in Pakistan
K. Lee (2017)
Human Antimicrobial Peptides and Proteins
G. Wang (2014)
Designed antimicrobial and antitumor peptides with high selectivity.
J. Hu (2011)
The emergence of peptides in the pharmaceutical business: From exploration to exploitation
T. Uhlig (2014)
Active targeting schemes for nanoparticle systems in cancer therapeutics.
J. D. Byrne (2008)
Doxil®--the first FDA-approved nano-drug: lessons learned.
Y. Barenholz (2012)
Extinction risk and conservation of the world’s sharks and rays
N. Dulvy (2014)
Clausenidin induces caspase-dependent apoptosis in colon cancer
P. Waziri (2016)
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer
K. Kato (2011)
Cancer statistics, 2016
R. Siegel (2016)
Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy.
S. Thamake (2011)
Down regulation of ADAM33 as a Predictive Biomarker of Aggressive Breast Cancer
G. C. Mânica (2017)
Phase II , multicenter , randomized trial of CPX - 351 ( cytarabine : daunor - ubicin ) liposome injection versus intensive salvage therapy in adults with fi rst relapse AML
J. E. Cortes (2014)
Quantum dots and carbon nanotubes in oncology : A review on emerging theranostic applications in
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
Krista Dubin (2016)
Selective cancer cell cytotoxicity of enantiomeric 9-mer peptides derived from beetle defensins depends on negatively charged phosphatidylserine on the cell surface
T. Iwasaki (2009)
Carbon nanotube exploration in cancer cell lines.
P. Kesharwani (2012)
Selective targeting of cancer cells using synthetic peptides.
M. Shadidi (2003)
Encapsulation of curcumin within poly(amidoamine) dendrimers for delivery to cancer cells
L. Wang (2013)
Antitumor and angiostatic peptides from frog skin secretions
H. Zoggel (2010)
Phase I and pharmacokinetic study of polymeric micelle-formulated paclitaxel in adult Chinese patients with advanced solid tumors
F. Lv (2014)
Decatropis bicolor (Zucc.) Radlk essential oil induces apoptosis of the MDA-MB-231 breast cancer cell line
C. Gómez (2016)
Epigenomes as therapeutic targets.
C. Hamm (2015)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Edgar Pérez-Herrero (2015)
Antimicrobial peptides stage a comeback
J. Fox (2013)
Peptide therapeutics: current status and future directions.
K. Fosgerau (2015)
New frontiers in nanotechnology for cancer treatment.
F. Alexis (2008)
Advances in silica based nanoparticles for targeted cancer therapy.
Yannan Yang (2016)
Graphene quantum dots for cancer targeted drug
D. Iannazzo (2017)
Applications of dendrimers for brain delivery and cancer therapy.
Sukrut Somani (2014)
メソ多孔性のデラフォサイト型CuCrO 2 とスピネル型CuCr 2 O 4 合成と触媒反応 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター
Zhang Peng (2013)
Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
Y. Huang (2015)
Prediction of anticancer peptides against MCF-7 breast cancer cells from the peptidomes of Achatina fulica mucus fractions
Teerasak E-kobon (2016)
Metabolic Syndrome Increases the Risk for Knee Osteoarthritis: A Meta-Analysis
H. Wang (2016)
Perspectives and potential applications of nanomedicine in breast and prostate cancer
Y. Liu (2013)
Long-lived self-renewing bone marrow-derived macrophages displace embryo-derived cells to inhabit adult serous cavities
C. Bain (2016)
Anticancer agents from marine sponges
Jianjun Ye (2015)
Polymeric micelles for multidrug delivery and combination therapy.
M. Aw (2013)
Roles of Hydrophobicity and Charge Distribution of Cationic Antimicrobial Peptides in Peptide-Membrane Interactions*
Lois M. Yin (2012)
Studies on anticancer activities of antimicrobial peptides.
D. Hoskin (2008)
Carbon nanotubes enhance the internalization of drugs by cancer cells and decrease their chemoresistance to cytostatics.
M. Mahmood (2013)
The research and applications of quantum dots as nanocarriers for targeted drug delivery and cancer therapy
Functional and structural characteristics of anticancer peptide Pep27 analogues
D. Lee (2004)
Advances of cancer therapy by nanotechnology.
X. Wang (2009)
The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy
M. Zhao (2016)
Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs.
Y. Lu (2013)
Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
S. A. Kooijmans (2016)
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes.
N. Dinauer (2005)
Conformational Flexibility Determines Selectivity and Antibacterial, Antiplasmodial, and Anticancer Potency of Cationic α-Helical Peptides*
Louic Vermeer (2012)
Nanotechnology and its Relationship to Interventional Radiology. Part I: Imaging
S. Power (2010)
Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery.
A. Lavasanifar (2002)
Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
D. Bharali (2009)
Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis
S. Watanabe (2010)
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
A. Ko (2013)
Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma
W. Pu (2016)
Mechanisms of Antimicrobial Peptide Action and Resistance
M. Yeaman (2003)
Cladosporol A triggers apoptosis sensitivity by ROS-mediated autophagic flux in human breast cancer cells
Mytre Koul (2017)
F. P. Silva (2012)
Anticancer activities of an antimicrobial peptide derivative of Ixosin-B amide.
Yu-Cheng Hsiao (2013)
Nanoparticle therapeutics: Technologies and methods for overcoming cancer.
B. B. S. Cerqueira (2015)
Hypermethylation of the TGF-β target, ABCA1 is associated with poor prognosis in ovarian cancer patients
Jian-Liang Chou (2014)
Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment
N. Martínez-Montiel (2016)
Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer
H. Giovinazzo (2015)
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.
R. Daillère (2016)
Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer.
Paul B. S. Kim (2011)
Phase I clinical trial
J. Yang (2014)
Cationic amphiphilic peptides with cancer-selective toxicity.
F. Schweizer (2009)
Ligand-targeted therapeutics in anticancer therapy
T. Allen (2002)
Can Some Marine-Derived Fungal Metabolites Become Actual Anticancer Agents?
N. Gomes (2015)
Cancer despite immunosurveillance: immunoselection and immunosubversion
L. Zitvogel (2006)
Surface modified dendrimers: synthesis and characterization for cancer targeted drug delivery.
Anupama Sharma (2011)
Pegylated dendrimer and its effect in fluorouracil loading and release for enhancing antitumor activity.
T. Ly (2013)
Climacostol reduces tumour progression in a mouse model of melanoma via the p53-dependent intrinsic apoptotic programme
C. Perrotta (2016)
Insect antimicrobial peptides: potential tools for the prevention of skin cancer
Miray Tonk (2016)
Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinum
J. Lee (2011)
Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa
Qing-Zhu Yang (2013)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
G. Chornokur (2015)
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
Bhairavi Srinageshwar (2017)
Oxygen-Carbon Nanotubes as a Chemotherapy Sensitizer for Paclitaxel in Breast Cancer Treatment
Yongkun Wang (2014)
Development of polymeric micelles for targeting intractable cancers
N. Nishiyama (2016)
Triazine dendrimers as drug delivery systems: from synthesis to therapy.
Jongdoo Lim (2012)
Clinical Developments in Nanotechnology for Cancer Therapy
J. Heidel (2010)
Analgesic-antitumor peptide induces apoptosis and inhibits the proliferation of SW480 human colon cancer cells
Yu Gu (2013)
Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML
J. Cortes (2015)
Epigenomics in cancer management
F. Costa (2010)
Carbon nanotubes as cancer therapeutic carriers and mediators
K. H. Son (2016)
Targeting tumors with peptides from natural sources.
S. K. Bhutia (2008)
Empty liposomes induce antitumoral effects associated with macrophage responses distinct from those of the TLR1/2 agonist Pam3CSK4 (BLP)
S. König (2013)
Effects of surface modification of quantum dots on viability and migration of triple-negative breast cancer cells.
H. Chen (2017)
Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy.
L. Kaplan (2014)
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
F. Danhier (2016)
Polymeric micelles for multidrug delivery
M. S. Aw (2013)
Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will
David Cano-Rodríguez (2016)
Amphipathicity Determines Different Cytotoxic Mechanisms of Lysine- or Arginine-Rich Cationic Hydrophobic Peptides in Cancer Cells.
X. Liu (2016)
Liver Regeneration Signature in Hepatitis B Virus (HBV)-Associated Acute Liver Failure Identified by Gene Expression Profiling
Oriel Nissim (2012)
Antimicrobial peptides: premises and promises.
K. Reddy (2004)
Nanotechnology for breast cancer therapy
T. Tanaka (2009)
This paper is referenced by
Characterization and functional analysis of liver-expressed antimicrobial peptide-2 (LEAP-2) from golden pompano Trachinotus ovatus (Linnaeus 1758).
B. Liu (2020)
Chetomin, a Hsp90/HIF1α pathway inhibitor, effectively targets lung cancer stem cells and non-stem cells
S. Min (2020)
Delivery of coumarin-containing all-trans retinoic acid derivatives via targeted nanoparticles encapsulating indocyanine green for chemo/photothermal/photodynamic therapy of breast cancer
Jia Jiao (2018)
General Evaluations of Nanoparticles
A. Kocak (2018)
Cationic amphipathic peptide analogs of cathelicidin LL‐37 as a probe in the development of antimicrobial/anticancer agents
Athanasios Tzitzilis (2020)
Are peptides a solution for the treatment of hyperactivated JAK3 pathways?
Anja Dullius (2019)
Hyaluronan-Arginine Interactions—An Ultrasound and ITC Study
Adam Jugl (2020)
Cloning and the expression of the protein fusion enterocin-nisin-epidermicin as a candidate for the treatment of gastric cancer
Zeinab Yousefy (2020)
Bacterial Proteinaceous Compounds With Multiple Activities Toward Cancers and Microbial Infection
G. Rodrigues (2019)
The antitumor activity of 4,4′-bipyridinium amphiphiles
Senlin Wang (2019)
Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review)
W. Chiangjong (2020)
[Progress in the mechanisms of anticancer peptides].
X. Qiao (2019)
Misc. medical devices and technologies
Paramita Basu (2019)
The role of antimicrobial peptides in plant immunity
M. L. Campos (2018)
Strategies for recombinant production of antimicrobial peptides with pharmacological potential
Kamila Botelho Sampaio de Oliveira (2020)
Pore-forming proteins: from defense factors to endogenous executors of cell death.
Haydee Mesa-Galloso (2020)
Seeds, fermented foods, and agricultural by-products as sources of plant-derived antibacterial peptides
Tsun-Thai Chai (2019)
Melittin-encapsulating peptide hydrogels for enhanced delivery of impermeable anticancer peptides.
Jue-Ping Feng (2020)
Antimicrobial Peptides and Nanotechnology, Recent Advances and Challenges
L. S. Biswaro (2018)
Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action
B. Meloni (2020)
A Review for Antimicrobial Peptides with Anticancer Properties: Re-purposing of Potential Anticancer Agents
Cuiyu Zhong (2020)
jmbReview The Antimicrobial Peptide CopA 3 Inhibits Clostridium difficile Toxin A-Induced Viability Loss and Apoptosis in Neural Cells
Ie Na Yoon (2019)
Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems.
Sobiya Zafar (2019)
Characterization and functional analysis of liver-expressed antimicrobial peptide-2 (LEAP-2) in Pelodiscus sinensis
Jianping Fu (2019)